Physical activity in cardiovascular disease prevention in patients with HIV/AIDS

Current Cardiovascular Risk Reports

Volumn 3, Issue 4, 2009, Pages 288-295

  Hand, Gregory A ^a   Jaggers, Jason R ^b   Lyerly, G William ^b   Dudgeon, Wesley D ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873498569     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0044-5     Document Type: Article

References (56)

1. Dudgeon WD, Phillips KD, Bopp CM, Hand GA: Physiological and psychological effects of exercise interventions in HIV disease. AIDS Patient Care STDS 2004, 18: 81-98.
2. Dudgeon WD, Phillips KD, Carson JA, et al.: Counteracting muscle wasting in HIV-infected individuals. HIV Med 2006, 7: 299-310.
3. Fauci AS: The AIDS epidemic-considerations for the 21st century. N Engl J Med 1999, 341: 1046-1050.
4. LaPerriere A, Ironson G, Antoni MH, et al.: Exercise and psychoneuroimmunology. Med Sci Sports Exerc 1994, 26: 182-190.
5. MacArthur RD, Levine SD, Birk TJ: Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc 1993, 25: 684-688.
6. Bozkurt B: Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies. Cardiovasc Toxicol 2004, 4: 243-260.
7. Chaves AA, Mihm MJ, Basuray A, et al.: HIV/AIDS-related cardiovascular disease. Cardiovasc Toxicol 2004, 4: 229-242.
8. Klein D, Hurley LB, Quesenberry CP Jr, Sidney S: Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?J Acquir Immune Defic Syndr 2002, 30: 471-477.
9. Friis-Moller N, Weber R, Reiss P, et al.: Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003, 17: 1179-1193.
10. Friis-Moller N, Sabin CA, Weber R, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349: 1993-2003.
11. Currier JS, Taylor A, Boyd F, et al.: Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003, 33: 506-512.
12. de Saint Martin L, Vandhuick O, Guillo P, et al.: Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis 2006, 185: 361-367.
13. Iloeje UH, Yuan Y, L'italien G, et al.: Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med 2005, 6: 37-44.
14. Jerico C, Knobel H, Calvo N, et al.: Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke 2006, 37: 812-817.
15. Triant VA, Lee H, Hadigan C, Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007, 92: 2506-2512.
16. Holmberg SD, Moorman AC, Williamson JM, et al.: Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002, 360: 1747-1748.
17. Bhasin S, Storer TW, Javanbakht M, et al.: Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 2000, 283: 763-770.
18. Roubenoff R, Wilson IB: Effect of resistance training on self-reported physical functioning in HIV infection. Med Sci Sports Exerc 2001, 33: 1811-1817.
19. Johnsen S, Dolan SE, Fitch KV, et al.: Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab 2006, 91: 4916-4924.
20. Law MG, Friis-Moller N, El Sadr WM, et al.: The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D: A: D Study. HIV Med 2006, 7: 218-230.
21. Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, et al.: Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262: 2395-2401.
22. Blair SN, Kampert JB, Kohl HW 3rd, et al.: Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996, 276: 205-210.
23. Wei M, Gibbons LW, Mitchell TL, et al.: The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 1999, 130: 89-96.
24. Hand GA, Phillips KD, Dudgeon WD, et al.: Moderate intensity exercise training reverses functional aerobic impairment in HIV-infected individuals. AIDS Care 2008, 20: 1066-1074.
25. Keyser RE, Peralta L, Cade WT, et al.: Functional aerobic impairment in adolescents seropositive for HIV: a quasiexperimental analysis. Arch Phys Med Rehabil 2000, 81: 1479-1484.
26. Lox CL, McAuley E, Tucker RS: Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population. Int J Behav Med 1996, 3: 55-69.
27. Terry L, Sprinz E, Stein R, et al.: Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy. Med Sci Sports Exerc 2006, 38: 411-417.
28. Perna FM, Laperriere A, Klimas N, et al.: Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Med Sci Sports Exerc 1999, 31: 973-979.
29. Kotler DP, Rosenbaum K, Wang J, Pierson RN: Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20: 228-237.
30. Nguyen-Duy TB, Nichaman MZ, Church TS, et al.: Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 2003, 284: E1065-E1071.
31. Grunfeld C, Rimland D, Gibert CL, et al.: Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr 2007, 46: 283-290.
32. Yarnell JW, Patterson CC, Thomas HF, Sweetnam PM: Central obesity: predictive value of skinfold measurements for subsequent ischaemic heart disease at 14 years follow-up in the Caerphilly Study. Int J Obes Relat Metab Disord 2001, 25: 1546-1549.
33. Jurca R, LaMonte MJ, Barlow CE, et al.: Association of muscular strength with incidence of metabolic syndrome in men. Med Sci Sports Exerc 2005, 37: 1849-1855.
34. Ruiz JR, Sui X, Lobelo F, et al.: Association between muscular strength and mortality in men: prospective cohort study. BMJ 2008, 337: a439.
35. Grinspoon S, Corcoran C, Parlman K, et al.: Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 2000, 133: 348-355.
36. Roubenoff R, Weiss L, McDermott A, et al.: A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 1999, 13: 1373-1375.
37. Spence DW, Galantino ML, Mossberg KA, Zimmerman SO: Progressive resistance exercise: effect on muscle function and anthropometry of a select AIDS population. Arch Phys Med Rehabil 1990, 71: 644-648.
38. Thoni GJ, Fedou C, Brun JF, et al.: Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia. Diabetes Metab 2002, 28: 397-404.
39. Grover SA, Coupal L, Gilmore N, Mukherjee J: Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol 2005, 95: 586-591.
40. Mensah GA, Dietz WH, Harris VB, et al.: Prevention and control of coronary heart disease and stroke-nomenclature for prevention approaches in public health: a statement for public health practice from the Centers for Disease Control and Prevention. Am J Prev Med 2005, 29: 152-157.
41. Engelson ES, Agin D, Kenya S, et al.: Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Metabolism 2006, 55: 1327-1336.
42. Brown TT, Li X, Cole SR, et al.: Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS 2005, 19: 1375-1383.
43. Acevedo M, Sprecher DL, Calabrese L, et al.: Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention'. Atherosclerosis 2002, 163: 349-354.
44. Lindegaard B, Hansen T, Hvid T, et al.: The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab 2008, 93: 3860-3869.
45. Chi D, Henry J, Kelley J, et al.: The effects of HIV infection on endothelial function. Endothelium 2000, 7: 223-242.
46. Nordoy I, Aukrust P, Muller F, Froland SS: Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections. Clin Immunol Immunopathol 1996, 81: 16-21.
47. Church TS, Barlow CE, Earnest CP, et al.: Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol 2002, 22: 1869-1876.
48. Ford ES: Does exercise reduce inflammation? Physical activity and C-reactive protein among U. S. adults. Epidemiology 2002, 13: 561-568.
49. Stringer WW, Berezovskaya M, O'Brien WA, et al.: The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients. Med Sci Sports Exerc 1998, 30: 11-16.
50. Terry L, Sprinz E, Ribeiro JP: Moderate and high intensity exercise training in HIV-1 seropositive individuals: a randomized trial. Int J Sports Med 1999, 20: 142-146.
51. Smith BA, Neidig JL, Nickel JT, et al.: Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS 2001, 15: 693-701.
52. Fillipas S, Oldmeadow LB, Bailey MJ, Cherry CL: A sixmonth, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial. Aust J Physiother 2006, 52: 185-190.
53. Dolan SE, Frontera W, Librizzi J, et al.: Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med 2006, 166: 1225-1231.
54. Robinson FP, Quinn LT, Rimmer JH: Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study. Biol Res Nurs 2007, 8: 177-185.
55. Fairfield WP, Treat M, Rosenthal DI, et al.: Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J Appl Physiol 2001, 90: 2166-2171.
56. Yarasheski KE, Tebas P, Stanerson B, et al.: Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. J Appl Physiol 2001, 90: 133-138.